In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis

FASEB Journal

Volumn 23, Issue 2, 2009, Pages 433-441

  Nakatani, Teruyo ^a   Sarraj, Bara ^b   Ohnishi, Mutsuko ^a   Densmore, Michael J ^a   Taguchi, Takashi ^c   Goetz, Regina ^d   Mohammadi, Moosa ^d   Lanske, Beate ^a   Razzaque, M Shawkat ^a,c  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NAGASAKI UNIVERSITY   (Japan)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcification; NaPi2a; PTH; Survival; Vitamin D

Indexed keywords

CALCITRIOL; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN;

ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; HYPOGONADISM; IN VIVO STUDY; LUNG EMPHYSEMA; MOUSE; MUSCLE ATROPHY; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; KIDNEY; MICE; MICE, KNOCKOUT; PHENOTYPE; PHOSPHATES; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; SURVIVAL RATE; URINALYSIS;

MUS;

EID: 59649091992     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-114397     Document Type: Article

References (39)

1. Yu, X., and White, K. E. (2005) FGF23 and disorders of phosphate homeostasis. Cytokine Growth Factor Rev. 16, 221-232
2. Razzaque, M. S., St-Arnaud, R., Taguchi, T., and Lanske, B. (2005) FGF-23, vitamin D and calcification: the unholy triad. Nephrol. Dial. Transpl. 20, 2032-2035
3. Memon, F., El-Abbadi, M., Nakatani, T., Taguchi, T., Lanske, B., and Razzaque, M. S. (2008) Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism? Kidney Int. 74, 566-570
4. Razzaque, M. S. (2007) Does renal ageing affect survival? Ageing Res. Rev. 6, 211-222
5. Razzaque, M. S., and Taguchi, T. (2002) Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med. Electron. Microsc. 35, 68-80
6. Taguchi, T., and Razzaque, M. S. (2007) The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol. Med. 13, 45-53
7. ADHR-Consortium (2000) Autosomal dominant hypophospha- taemic rickets is associated with mutations in FGF23. The ADHR Consortium. Nat. Genet. 26, 345-348
8. Benet-Pages, A., Orlik, P., Strom, T. M., and Lorenz-Depiereux, B. (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum. Mol. Genet. 14, 385-390
9. Bai, X., Miao, D., Li, J., Goltzman, D., and Karaplis, A. C. (2004) Transgenic mice overexpressing human fibroblast growth factor 23(R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145, 5269-5279
10. Shimada, T., Kakitani, M., Yamazaki, Y., Hasegawa, H., Takeu- chi, Y., Fujita, T., Fukumoto, S., Tomizuka, K., and Yamashita, T. (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J. Clin. Invest. 113, 561-568
11. Sitara, D., Razzaque, M. S., St-Arnaud, R., Huang, W., Taguchi, T., Erben, R. G., and Lanske, B. (2006) Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am. J. Pathol. 169, 2161-2170
12. Liu, S., Zhou, J., Tang, W., Jiang, X., Rowe, D. W., and Quarles, L. D. (2006) Pathogenic role of Fgf23 in Hyp mice. Am. J. Physiol. Endocrinol. Metab. 291, E38-49
13. Urakawa, I., Yamazaki, Y., Shimada, T., Iijima, K., Hasegawa, H., Okawa, K., Fujita, T., Fukumoto, S., and Yamashita, T. (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444, 770-774
14. Kurosu, H., Ogawa, Y., Miyoshi, M., Yamamoto, M., Nandi, A., Rosenblatt, K. P., Baum, M. G., Schiavi, S., Hu, M. C., Moe, O. W., and Kuro-o, M. (2006) Regulation of fibroblast growth factor-23 signaling by klotho. J. Biol. Chem. 281, 6120-6123
15. Li, S. A., Watanabe, M., Yamada, H., Nagai, A., Kinuta, M., and Takei, K. (2004) Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct. Funct. 29, 91-99
16. Wang, H., Yoshiko, Y., Yamamoto, R., Minamizaki, T., Kozai, K., Tanne, K., Aubin, J. E., and Maeda, N. (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone. Miner. Res. 23, 939-948
17. Yu, X., Ibrahimi, O. A., Goetz, R., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., and White, K. E. (2005) Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology 146, 4647-4656
18. Razzaque, M. S., and Lanske, B. (2007) The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J. Endocrinol. 194, 1-10
19. Liu, D., Nazneen, A., Taguchi, T., and Razzaque, M. S. (2008) Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis. Am. J. Nephrol. 28, 555-568
20. Zha, Y., Taguchi, T., Nazneen, A., Shimokawa, I., Higami, Y., and Razzaque, M. S. (2008) Genetic suppression of GH-IGF-1 activity, combined with lifelong caloric restriction, prevents age-related renal damage and prolongs the life span in rats. Am. J. Nephrol. 28, 755-764
21. Razzaque, M. S., Soegiarto, D. W., Chang, D., Long, F., and Lanske, B. (2005) Conditional deletion of Indian hedgehog from collagen type 2alpha1-expressing cells results in abnormal endochondral bone formation. J. Pathol. 207, 453-461
22. Razzaque, M. S., and Taguchi, T. (1997) Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis. J. Pathol. 183, 24-29
23. Zha, Y., Le, V. T., Higami, Y., Shimokawa, I., Taguchi, T., and Razzaque, M. S. (2006) Life-long suppression of growth hormone-insulin-like growth factor I activity in genetically altered rats could prevent age-related renal damage. Endocrinology 147, 5690-5698
24. Razzaque, M. S., Nazneen, A., and Taguchi, T. (1998) Immunolocalization of collagen and collagen-binding heat shock protein 47 in fibrotic lung diseases. Mod. Pathol. 11, 1183-1188
25. Kirkeby, S., and Thomsen, C. E. (2005) Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J. Immunol. Methods 301, 102-113
26. Razzaque, M. S., Sitara, D., Taguchi, T., St-Arnaud, R., and Lanske, B. (2006) Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J. 20, 720-722
27. Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., Yu, X., White, K. E., Inagaki, T., Kliewer, S. A., Yamamoto, M., Kurosu, H., Ogawa, Y., Kuro-o, M., Lanske, B., Razzaque, M. S., and Mohammadi, M. (2007) Molecular insights into the klotho- dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428
28. Razzaque, M. S., and Lanske, B. (2006) Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol. Med. 12, 298-305
29. Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., Iwasaki, H., Iida, A., Shiraki-Iida, T., Nishikawa, S., Nagai, R., and Nabeshima, Y. I. (1997) Mutation ofthe mouse klotho gene leads to a syndrome resembling ageing. Nature 390, 45-51
30. Yamazaki, Y., Tamada, T., Kasai, N., Urakawa, I., Aono, Y., Hasegawa, H., Fujita, T., Kuroki, R., Yamashita, T., Fukumoto, S., and Shimada, T. (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J. Bone Miner. Res. 23, 1509-1518
31. Lanske, B., and Razzaque, M. S. (2007) Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr. Opin. Nephrol. Hypertens. 16, 311-318
32. Lanske, B., and Razzaque, M. S. (2007) Premature aging in klotho mutant mice: cause or consequence? Ageing Res. Rev. 6, 73-79
33. Ichikawa, S., Imel, E. A., Kreiter, M. L., Yu, X., Mackenzie, D. S., Sorenson, A. H., Goetz, R., Mohammadi, M., White, K. E., and Econs, M. J. (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J. Clin. Invest. 117, 2684-2691
34. Pfister, M. F., Ruf, I., Stange, G., Ziegler, U., Lederer, E., Biber, J., and Murer, H. (1998) Parathyroid hormone leads to the lysosomal degradation of the renal type II Na/Pi cotransporter. Proc. Natl. Acad. Sci. U. S. A. 95, 1909-1914
35. Keusch, I., Traebert, M., Lotscher, M., Kaissling, B., Murer, H., and Biber, J. (1998) Parathyroid hormone and dietary phosphate provoke a lysosomal routing of the proximal tubular Na/Pi-cotransporter type II. Kidney Int. 54, 1224-1232
36. Miyamoto, K., Ito, M., Tatsumi, S., Kuwahata, M., and Segawa, H. (2007) New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am. J. Nephrol. 27, 503-515
37. Nabeshima, Y., and Imura, H. (2008) alpha-Klotho: a regulator that integrates calcium homeostasis. Am. J. Nephrol. 28, 455-464
38. Razzaque, M. S. (2008) Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma? Nephrol. Dial. Transplant 23, 459-461
39. Razzaque, M. S. (2007) Can fibroblast growth factor 23 fine-tune therapies for diseases of abnormal mineral ion metabolism? Nat. Clin. Pract. Endocrinol. Metab. 3, 788-789